Knee embolism is an outpatient procedure that blocks or reduces blood flow to the knee, usually to treat conditions that ...

Despite guidelines recommending other anticoagulants for people hospitalized with acute pulmonary embolism (PE), old habits ...

Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational Device ...

The objective of this study was to investigate the risk of acute internal jugular, subclavian, and axillary deep venous thrombosis (upper torso DVT [UTDVT]) and pulmonary embolism (PE) and the ...

This 75-year-old man complained of unbearable pain in both feet, at rest, of two months’ duration. Physical examination revealed blue toes, fissures, petechial hemorrhages, and ulcerating ...

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

AngioDynamics, Inc. (ANGO), a New York-based medical technology company Monday announced the publication of results from the Acute ...

MARIA, a 42-year-old teacher with an energetic spirit, had always been an active woman. However, one morning after a long ...

Inquis Medical, which is developing therapies for venous thromboembolic diseases, announced the completion of patient ...

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...